Nidan Laboratories and Healthcare (NSE:NIDAN) FCF Yield %: 0.00 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NIDAN Nidan Laboratories and Healthcare Ltd NSE:NIDAN
67 GF Score
Price ₹13.95
View Full Analysis

What is Nidan Laboratories and Healthcare FCF Yield %?

Nidan Laboratories and Healthcare NSE:NIDAN 67 FCF Yield % is 0.00 as of Jul. 14, 2026. GuruFocus rates NSE:NIDAN with a GF Score™ of 67/100.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Nidan Laboratories and Healthcare's Trailing 12-Month Free Cash Flow is ₹13.4 Mil, and Market Cap is ₹193.9 Mil. Therefore, Nidan Laboratories and Healthcare's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Nidan Laboratories and Healthcare's FCF Yield % or its related term are showing as below:


NSE:NIDAN's FCF Yield % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -1.36
* Ranked among companies with meaningful FCF Yield % only.

Nidan Laboratories and Healthcare's FCF Margin % for the quarter that ended in Mar. 2025 was 5.32%.

Nidan Laboratories and Healthcare FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Nidan Laboratories and Healthcare FCF Yield % Related Terms

Nidan Laboratories and Healthcare FCF Yield % Historical Data

* Premium members only.

The historical data trend for Nidan Laboratories and Healthcare's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nidan Laboratories and Healthcare FCF Yield % Chart

Nidan Laboratories and Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
FCF Yield %
Get a 7-Day Free Trial 0.00 1.63 21.89 12.72 5.81

Nidan Laboratories and Healthcare Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -4.29 0.00 0.00 2.59 6.47

NSE:NIDAN vs TMO, DHR, IDXX: FCF Yield % Comparison

For the Diagnostics & Research subindustry, Nidan Laboratories and Healthcare's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nidan Laboratories and Healthcare FCF Yield % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Nidan Laboratories and Healthcare's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Nidan Laboratories and Healthcare's FCF Yield % falls into.


NSE:NIDAN
67GF Score
Nidan Laboratories and Healthcare Ltd NSE:NIDAN
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nidan Laboratories and Healthcare FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Nidan Laboratories and Healthcare's FCF Yield % for the fiscal year that ended in Mar. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=13.362 / 230.045
=5.81%

Nidan Laboratories and Healthcare's annualized FCF Yield % for the quarter that ended in Mar. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=7.44 * 2 / 230.045
=6.47%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 0.00 mean?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a FCF Yield % of 0.00 as of Jul. 14, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Nidan Laboratories and Healthcare and its competitors.
Is Nidan Laboratories and Healthcare's FCF Yield % too high?
Nidan Laboratories and Healthcare's current FCF Yield % is 0.00. Overall, Nidan Laboratories and Healthcare has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Nidan Laboratories and Healthcare's FCF Yield % compare to TMO and DHR?
Nidan Laboratories and Healthcare's FCF Yield % of 0.00 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Diagnostics & Research company?
A good FCF Yield % depends on the Medical Diagnostics & Research industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Nidan Laboratories and Healthcare and its competitors. Nidan Laboratories and Healthcare's current FCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nidan Laboratories and Healthcare stock overvalued right now?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a current FCF Yield % of 0.00. The current FCF Yield % is 0.00. Nidan Laboratories and Healthcare's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Nidan Laboratories and Healthcare (NSE:NIDAN), the current FCF Yield % is 0.00 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nidan Laboratories and Healthcare Business Description

Address Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa Bunglow, Behind Aarti Apartment, Virar West, Palghar, Virar, MH, IND, 401303
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.
67GF Score

Get the complete analysis for NSE:NIDAN

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.95
Price